| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
12,756 |
7,906 |
$128K |
| G9012 |
Other specified case management service not elsewhere classified |
1,513 |
815 |
$111K |
| 0510 |
|
186 |
168 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
837 |
823 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
1,482 |
1,462 |
$918.15 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,576 |
6,476 |
$565.67 |
| 80061 |
Lipid panel |
4,160 |
4,099 |
$530.93 |
| 86480 |
|
572 |
563 |
$432.83 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,155 |
1,138 |
$424.57 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,155 |
1,138 |
$423.76 |
| 80053 |
Comprehensive metabolic panel |
5,567 |
5,126 |
$416.71 |
| 86703 |
|
1,906 |
1,883 |
$361.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,260 |
2,222 |
$316.02 |
| 82274 |
|
1,517 |
1,501 |
$224.42 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,750 |
4,308 |
$170.98 |
| 86780 |
|
975 |
966 |
$155.93 |
| 86706 |
|
935 |
923 |
$143.68 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,701 |
2,578 |
$134.89 |
| 87340 |
|
989 |
982 |
$114.26 |
| 90686 |
|
463 |
463 |
$103.15 |
| 82043 |
|
1,683 |
1,648 |
$87.66 |
| 85027 |
|
2,054 |
1,993 |
$76.18 |
| 86705 |
|
341 |
338 |
$75.16 |
| 82540 |
|
1,695 |
1,660 |
$69.40 |
| 87338 |
|
183 |
174 |
$63.43 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
146 |
146 |
$56.84 |
| 76830 |
Ultrasound, transvaginal |
17 |
17 |
$48.89 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,004 |
1,962 |
$44.58 |
| 99442 |
|
1,837 |
1,750 |
$37.34 |
| 82607 |
|
562 |
555 |
$37.19 |
| 71046 |
Radiologic examination, chest; 2 views |
129 |
128 |
$35.92 |
| 84439 |
|
373 |
362 |
$31.40 |
| 83880 |
|
54 |
52 |
$29.85 |
| 84443 |
Thyroid stimulating hormone (TSH) |
509 |
494 |
$29.22 |
| 85610 |
|
1,269 |
1,085 |
$27.68 |
| 81001 |
|
1,516 |
1,380 |
$27.12 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
714 |
669 |
$26.83 |
| 86762 |
|
234 |
233 |
$25.58 |
| 82728 |
|
447 |
440 |
$23.90 |
| 86765 |
|
206 |
205 |
$22.90 |
| 81025 |
|
285 |
276 |
$21.25 |
| 83550 |
|
538 |
527 |
$20.46 |
| 83540 |
|
548 |
536 |
$16.98 |
| 82565 |
|
301 |
295 |
$12.81 |
| 86738 |
|
190 |
190 |
$11.77 |
| 84460 |
|
431 |
423 |
$11.38 |
| 82947 |
|
234 |
230 |
$10.70 |
| 99441 |
|
3,515 |
3,290 |
$10.16 |
| 82570 |
|
54 |
51 |
$9.10 |
| 84450 |
|
377 |
369 |
$8.78 |
| 80076 |
|
893 |
873 |
$6.32 |
| 83735 |
|
167 |
131 |
$5.90 |
| 85730 |
|
28 |
28 |
$5.29 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
260 |
259 |
$4.46 |
| 81003 |
|
326 |
305 |
$1.94 |
| 91300 |
|
127 |
124 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,350 |
4,904 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
350 |
344 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,218 |
6,135 |
$0.00 |
| 86900 |
|
46 |
36 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
230 |
227 |
$0.00 |
| 84100 |
|
131 |
114 |
$0.00 |
| 98966 |
|
252 |
217 |
$0.00 |
| 76642 |
|
26 |
26 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
59 |
57 |
$0.00 |
| 90658 |
|
87 |
87 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
501 |
287 |
$0.00 |
| 3077F |
|
326 |
305 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
207 |
199 |
$0.00 |
| 3078F |
|
1,865 |
1,692 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
387 |
384 |
$0.00 |
| 3051F |
|
190 |
187 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
15 |
12 |
$0.00 |
| G9920 |
Screening performed and negative |
24 |
24 |
$0.00 |
| 96160 |
|
37 |
37 |
$0.00 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
24 |
24 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
113 |
112 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17 |
17 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
51 |
51 |
$0.00 |
| 83970 |
|
27 |
27 |
$0.00 |
| 90715 |
|
14 |
14 |
$0.00 |
| 87210 |
|
33 |
32 |
$0.00 |
| 86708 |
|
12 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
18 |
18 |
$0.00 |
| 3046F |
|
34 |
33 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$0.00 |
| 90653 |
|
21 |
21 |
$0.00 |
| 99201 |
|
18 |
18 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,104 |
3,918 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
16,128 |
14,217 |
$0.00 |
| 85652 |
|
677 |
654 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$0.00 |
| 86141 |
|
696 |
671 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,523 |
2,447 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
49 |
49 |
$0.00 |
| 99606 |
|
184 |
173 |
$0.00 |
| 3052F |
|
12 |
12 |
$0.00 |
| 3075F |
|
326 |
313 |
$0.00 |
| 4450F |
|
38 |
37 |
$0.00 |
| 3074F |
|
1,522 |
1,402 |
$0.00 |
| 99443 |
|
319 |
311 |
$0.00 |
| 86593 |
|
165 |
165 |
$0.00 |
| 86592 |
|
203 |
203 |
$0.00 |
| 82105 |
|
13 |
12 |
$0.00 |
| 3044F |
|
693 |
693 |
$0.00 |
| 90677 |
|
24 |
24 |
$0.00 |
| 87088 |
|
59 |
56 |
$0.00 |
| 86901 |
|
46 |
36 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
36 |
24 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
329 |
326 |
$0.00 |
| 1111F |
|
597 |
557 |
$0.00 |
| 3079F |
|
262 |
255 |
$0.00 |
| 0064A |
|
43 |
43 |
$0.00 |
| 88142 |
|
105 |
105 |
$0.00 |
| 74174 |
|
12 |
12 |
$0.00 |
| 1220F |
|
14 |
12 |
$0.00 |
| 91301 |
|
120 |
120 |
$0.00 |
| 90656 |
|
158 |
158 |
$0.00 |
| 99243 |
|
23 |
23 |
$0.00 |
| 92250 |
|
38 |
38 |
$0.00 |
| 80422 |
|
14 |
12 |
$0.00 |
| 86850 |
|
31 |
25 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
18 |
18 |
$0.00 |
| 90739 |
|
25 |
25 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$0.00 |
| 91306 |
|
40 |
40 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |